Latest News

Senator Durbin: Inflammatory, Hateful Rhetoric Does Not Reflect Who We Are as Americans

Senator, Illinois Methodist Bishop Sally Dyck, and others reject efforts to exclude all Muslim immigrants WASHINGTON, DC –(ENEWSPF)–December 8, 2015.  Amid statements and inflammatory rhetoric that unfairly vilify billions of Muslims, U.S. Senator Dick Durbin (D-IL) spoke on the Senate Floor today to call for thoughtfulness and tolerance that reflect[Read More…]

CAIR-Philadelphia Welcomes Investigation of Pig’s Head Thrown at Mosqu

PHILADELPHIA, PA–(ENEWSPF)–December 8, 2015 — The Philadelphia chapter of the Council on American-Islamic Relations (CAIR-Philadelphia) today welcomed the ongoing investigations by Philadelphia police and FBI of an incident in which a severed pig’s head was tossed at a mosque on Sunday night. Surveillance video outside the Al-Aqsa Islamic Society, in[Read More…]

AARP Praises Passage of Transportation Safety Measures in FAST Act, Pushes for More Action

Washington, DC—(ENEWSPF)–December 8, 2015.  Today AARP praised Congress for passing, and President Obama for signing into law, the bipartisan Fixing America’s Surface Transportation Act (FAST Act) which addresses the disturbing trend of rising pedestrian fatality rates. The FAST Act will provide states and communities with the certainty they need to[Read More…]

UN Promoting Potentially Genocidal Policy at World Climate Summit

PARIS, FRANCE –(ENEWSPF)–December 8, 2015.   At the foot of a miniature Eiffel Tower, civil society, environmentalists and Indigenous Peoples rejected REDD, a carbon market mechanism, land-grabbing false solution to climate change that could potentially cause genocide, at the World Climate Summit today. According to Tom Goldtooth, Director of Indigenous[Read More…]

FDA Approves First Recombinant von Willebrand Factor to Treat Bleeding Episodes

Silver Spring, Maryland–(ENEWSPF)–December 8, 2015. The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD). Vonvendi is the first FDA-approved recombinant von Willebrand factor, and is approved for the on-demand (as[Read More…]

Most read stories this week

Take a Survey

ARCHIVES